Is carbamazepine classified as a controlled substance in Tennessee?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Carbamazepine is NOT a Controlled Substance in Tennessee

Carbamazepine is not classified as a controlled substance in Tennessee or anywhere in the United States. It is a prescription medication used for epilepsy, trigeminal neuralgia, and bipolar disorder, but it does not fall under federal or state controlled substance schedules 1.

Key Points About Carbamazepine's Legal Status

  • Prescription Required: Carbamazepine requires a valid prescription from a licensed healthcare provider but is not subject to the additional regulations that apply to controlled substances 1

  • No DEA Scheduling: Unlike opioids, benzodiazepines, or stimulants, carbamazepine has no abuse potential recognized by the Drug Enforcement Administration and carries no controlled substance classification

  • Standard Prescription Practices Apply: Prescribers can write refills without the restrictions imposed on Schedule II-V medications

Context: Tennessee's Controlled Substance Regulations

Tennessee has been active in scheduling certain medications due to abuse concerns. For example:

  • Gabapentin (another antiepileptic) has been scheduled as a controlled substance in some states, including regulatory changes that affected medication adherence among epilepsy patients 2

  • Tennessee data shows involvement of controlled substances like opioids, benzodiazepines, and gabapentin in overdose deaths, but carbamazepine is not mentioned in this context 3

Clinical Implications

While carbamazepine is not controlled, prescribers must still:

  • Follow standard prescribing practices and documentation
  • Monitor for serious adverse reactions, particularly severe cutaneous reactions (SJS/TEN) which have mortality rates up to 5% for SJS and >30% for TEN 4
  • Consider HLA genotype testing before initiating therapy to reduce hypersensitivity reaction risk 4
  • Be aware of drug-drug interactions and the need for therapeutic drug monitoring (target range 4-12 μg/mL) 1

Bottom line: Carbamazepine can be prescribed with standard prescription practices in Tennessee without controlled substance restrictions.

Related Questions

What are the indications, dosing guidelines, contraindications, monitoring requirements, and alternative therapies for Tegretol (carbamazepine)?
What are the recommended starting dose, titration schedule, maximum dose, monitoring parameters, contraindications, drug interactions, and alternative therapies for carbamazepine in an adult patient without known contraindications?
Is it appropriate to prescribe carbamazepine 300 mg every 6 hours using the chewable tablet formulation?
What are the appropriate dosing regimens for carbamazepine (Tegretol) in adults, children older than 12 years, and elderly patients, including recommended starting doses, titration intervals, and maximum daily doses?
How often should laboratory monitoring be performed for a patient taking carbamazepine?
Is white noise safe for a healthy infant (0‑12 months) without hearing impairment?
Is it appropriate to start a patient on ciprofloxacin 500 mg orally twice daily for three days and initiate levothyroxine therapy, and what dosing and timing considerations are needed?
What is the appropriate dosing and safety considerations for administering oseltamivir (Tamiflu) to infants aged two weeks to one year?
What are the most common causes of new‑onset atrial fibrillation in a 59‑year‑old woman with no prior cardiac history?
How should I manage a patient with atrial fibrillation who declines anticoagulation, including assessment of CHA₂DS₂‑VASc score and alternative stroke‑prevention and rate‑control measures?
What is the most likely diagnosis for a healthy adult presenting with dysuria, urinary urgency, and low-volume voids without fever or flank pain?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.